U.S. Food and Drug Administration (FDA) approved first drug oral to treat postpartum depression. It is the drug zuranolone, which will be marketed under the brand name Zurzuvae and is being developed by Sage Therapeutics. Its price is still unknown. According to FDA recommendations, it should be taken once daily for two weeks with an RDA of 50 mg.
So far, treatment for postpartum depression only works as a method intravenous injection In some medical centers. The only options for women with this disorder are psychotherapy or traditional antidepressant medication. The latter usually takes some time to take effect.However, with this new drug, women will be able to observe results in three days Start treatment.
“Postpartum depression is a serious and life-threatening condition in which women experience feelings of sadness, guilt, worthlessness and, in severe cases, hurt yourself or your child. And because it disrupts the mother-baby bond, it can also have an impact on a child’s physical and emotional development.access to oral medication will be Favorable choice For the many women who are dealing with extreme and sometimes life-threatening emotions,” she said. Tiffany R. FacioneDirector, Division of Psychiatry, FDA Center for Drug Evaluation and Research.
Ashima Ahmed“About one in eight women experience symptoms of postpartum depression after giving birth, and among women reporting symptoms, 75% did not receive treatmentยป. However, the FDA warns that Zurzuvae may affect a person’s ability to drive and perform other potentially dangerous activities. Patients may also not be able to assess the extent of their injury. To reduce the risk of injury, patients should not drive or operate heavy machinery during treatment. at least 12 hours later take medicine.
In addition, they exhibited side effect Most common: Drowsiness, dizziness, diarrhea, fatigue, nasopharyngitis (common cold), and urinary tract infection.Likewise, they explain that the use of Zurzuvae, in addition to causing harm to the fetus, has the potential to lead to suicidal thoughts and behavior, and therefore recommends that women who decide to take the drug should use effective method of contraception While they are taking the medicine and for a week after taking it.